Certara Announces Participation in Upcoming Jefferies Global Healthcare Conference

Certara, Inc. CERT, a frontrunner in the field of biosimulation software and technology services, has publicly stated its intention to partake in the forthcoming Jefferies Global Healthcare Conference. The announcement was made on May 29, 2024, indicating the company's ongoing engagement with the healthcare investment community. Headquartered in Princeton, New Jersey, Certara is committed to advancing drug discovery and development through its sophisticated in silico tools.

Company Profile

With a primary focus on biosimulation for pharmaceutical research, CERT offers a suite of applications designed to support clients across various stages of drug development. From the early stages of drug discovery, through preclinical and clinical research, to regulatory submissions and market access strategies, Certara stands as an integral resource for entities in the pharmaceutical industry. This participation at a high-profile event such as the Jefferies Global Healthcare Conference signifies the company’s dedication to maintaining an active role in the discussion of healthcare innovation and investment.

Investment Community Engagement

The decision for management to engage in this event underscores CERT's agenda to maintain close communications with the investment community. Participation in industry conferences is a critical component for companies like Certara to showcase their advancements, forge new connections, and stay abreflare of the competitive landscape within the healthcare sector. These forums provide the opportunity for investors to gain insights into the company’s progress and strategic direction.

Certara, Healthcare, Conference